PRIMAQUINE PHOSPHATE

PRIMAQUINE PHOSPHATE was reported 87 times

PRIMAQUINE PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLASMODIUM VIVAX INFECTION 7 0.3043
1 SPLEEN PALPABLE 1 0.0130
2 CONJUNCTIVAL PALLOR 2 0.0110
3 METHAEMOGLOBINAEMIA 20 0.0086
4 BILIRUBIN URINE PRESENT 1 0.0084
5 MURDER 1 0.0070
6 HAEMOGLOBIN URINE PRESENT 1 0.0049
7 PERIORBITAL DISORDER 1 0.0049
8 BRONCHOSCOPY 1 0.0042
9 TONGUE SPASM 1 0.0032
10 HAEMOGLOBINURIA 3 0.0027
11 POST THROMBOTIC SYNDROME 1 0.0022
12 INJURY ASPHYXIATION 1 0.0022
13 PO2 INCREASED 1 0.0020
14 CRYSTALLURIA 1 0.0018
15 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
16 MALARIA 1 0.0014
17 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
18 BRAIN STEM SYNDROME 1 0.0013
19 PO2 DECREASED 1 0.0009
20 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
21 VESTIBULAR DISORDER 1 0.0008
22 LIP DISCOLOURATION 1 0.0008
23 DRUG CLEARANCE DECREASED 1 0.0008
24 LUNG CONSOLIDATION 2 0.0007
25 CYANOSIS 8 0.0005
26 DENGUE FEVER 1 0.0004
27 GRANULOCYTOPENIA 2 0.0004
28 DYSPNOEA AT REST 1 0.0003
29 HAEMOLYTIC ANAEMIA 3 0.0003
30 CHEST X-RAY ABNORMAL 1 0.0003
31 ORTHOPNOEA 1 0.0003
32 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
33 TYPE I HYPERSENSITIVITY 1 0.0003
34 DRUG ERUPTION 5 0.0003
35 MACULOPATHY 1 0.0003
36 HYPOPHOSPHATAEMIA 2 0.0003
37 CHROMATURIA 6 0.0003
38 COMMUNICATION DISORDER 1 0.0003
39 HAEMOLYSIS 2 0.0003
40 NAIL DISCOLOURATION 1 0.0003
41 ENURESIS 1 0.0002
42 LIP OEDEMA 1 0.0002
43 DYSPHEMIA 1 0.0002
44 RESPIRATORY RATE INCREASED 2 0.0002
45 LYMPHOPENIA 3 0.0002
46 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
47 ERYSIPELAS 1 0.0002
48 JAW DISORDER 1 0.0002
49 NEUTROPHILIA 1 0.0002
50 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
51 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
52 ADRENAL INSUFFICIENCY 2 0.0002
53 INCOHERENT 1 0.0002
54 HAND FRACTURE 1 0.0001
55 POLYURIA 1 0.0001
56 FACE OEDEMA 2 0.0001
57 PURPURA 1 0.0001
58 JAUNDICE 3 0.0001
59 AUTOIMMUNE DISORDER 1 0.0001
60 NEPHROPATHY TOXIC 1 0.0001
61 SPLENOMEGALY 1 0.0001
62 HYPOXIA 3 0.0001
63 HEPATIC FUNCTION ABNORMAL 3 0.0001
64 BRAIN OEDEMA 1 0.0001
65 PULMONARY CONGESTION 1 0.0001
66 DISORIENTATION 3 0.0001
67 DRUG INTERACTION 12 0.0001
68 BLOOD BILIRUBIN INCREASED 2 0.0001
69 TACHYPNOEA 1 0.0001
70 PALLOR 2 0.0001
71 PNEUMONITIS 2 0.0001
72 HYPONATRAEMIA 4 0.0001
73 SKIN REACTION 1 0.0001
74 PULMONARY MASS 1 0.0001
75 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
76 BLOOD UREA INCREASED 1 0.0001
77 HYPERKALAEMIA 2 0.0001
78 ISCHAEMIC STROKE 1 0.0001
79 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
80 CHOLESTASIS 1 0.0001
81 HAEMATOCRIT DECREASED 1 0.0001
82 RIB FRACTURE 1 0.0000
83 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
84 STEVENS-JOHNSON SYNDROME 1 0.0000
85 TRANSAMINASES INCREASED 1 0.0000
86 HYPOKALAEMIA 2 0.0000
87 RESPIRATORY FAILURE 3 0.0000
88 ENCEPHALOPATHY 1 0.0000
89 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
90 SYNCOPE 4 0.0000
91 MOOD ALTERED 1 0.0000
92 RESPIRATORY DISTRESS 1 0.0000
93 FEELING COLD 1 0.0000
94 PANCYTOPENIA 2 0.0000
95 OXYGEN SATURATION DECREASED 2 0.0000
96 RED BLOOD CELL COUNT DECREASED 1 0.0000
97 PSYCHOTIC DISORDER 1 0.0000
98 HEPATIC FAILURE 1 0.0000
99 DISCOMFORT 2 0.0000
100 DRUG-INDUCED LIVER INJURY 1 0.0000
101 EYE DISORDER 1 0.0000
102 VISUAL ACUITY REDUCED 1 0.0000
103 ANGER 1 0.0000
104 NEUTROPENIA 4 0.0000
105 PYREXIA 10 0.0000
106 DELIRIUM 1 0.0000
107 C-REACTIVE PROTEIN INCREASED 1 0.0000
108 PANIC ATTACK 1 0.0000
109 DYSPNOEA EXERTIONAL 1 0.0000
110 ABNORMAL BEHAVIOUR 1 0.0000
111 POLLAKIURIA 1 0.0000
112 DRY SKIN 3 0.0000
113 ARRHYTHMIA 1 0.0000
114 HYPOGLYCAEMIA 1 0.0000
115 HEART RATE INCREASED 2 0.0000
116 LEUKOPENIA 1 0.0000
117 AGGRESSION 1 0.0000
118 NERVOUSNESS 1 0.0000
119 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
120 TREATMENT NONCOMPLIANCE 1 0.0000
121 MEDICATION ERROR 1 0.0000
122 MYALGIA 3 0.0000
123 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
124 DEEP VEIN THROMBOSIS 1 0.0000
125 BLOOD CREATININE INCREASED 1 0.0000
126 DECREASED APPETITE 3 0.0000
127 CONFUSIONAL STATE 2 0.0000
128 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
129 COMPLETED SUICIDE 1 0.0000
130 RENAL IMPAIRMENT 1 0.0000
131 INTENTIONAL PRODUCT MISUSE 1 0.0000
132 TACHYCARDIA 1 0.0000
133 SUICIDAL IDEATION 1 0.0000
134 DYSPNOEA 6 0.0000
135 PULMONARY EMBOLISM 1 0.0000
136 HYPOTENSION 2 0.0000
137 DRUG INEFFECTIVE 13 0.0000
138 HAEMOGLOBIN DECREASED 1 0.0000
139 DEPRESSION 2 0.0000
140 CHILLS 1 0.0000
141 DISEASE PROGRESSION 1 0.0000
142 FEELING ABNORMAL 2 0.0000
143 JOINT SWELLING 1 0.0000
144 OEDEMA PERIPHERAL 1 0.0000
145 VISUAL IMPAIRMENT 1 0.0000
146 HEADACHE 5 0.0000
147 RENAL FAILURE 1 0.0000
148 OFF LABEL USE 6 0.0000
149 HOSPITALISATION 1 0.0000
150 PERIPHERAL SWELLING 1 0.0000
151 VOMITING 3 0.0000
152 TREMOR 1 0.0000
153 URTICARIA 1 0.0000
154 MUSCLE SPASMS 1 0.0000
155 HYPERSENSITIVITY 1 0.0000
156 PRODUCT USE ISSUE 1 0.0000
157 ANAEMIA 1 0.0000
158 ERYTHEMA 1 0.0000
159 DIARRHOEA 3 0.0000
160 OVERDOSE 1 0.0000
161 BACK PAIN 1 0.0000
162 NAUSEA 3 0.0000
163 COUGH 1 0.0000
164 PAIN IN EXTREMITY 1 0.0000
165 CONDITION AGGRAVATED 1 0.0000
166 ASTHENIA 1 0.0000
167 FATIGUE 2 0.0000
168 MALAISE 1 0.0000
169 DIZZINESS 1 0.0000